# S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer

> **NCT00025493** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 27 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00025493
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-10
- **Primary completion:** 2007-06
- **Final completion:** 2008-06
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2013-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025493, "S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00025493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*